ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,066,000 | +5.0% | 2,496,297 | -14.5% | 0.72% | -2.9% |
| Q2 2022 | $5,778,000 | -38.5% | 2,918,260 | -43.2% | 0.75% | -30.9% |
| Q1 2022 | $9,402,000 | +5.0% | 5,137,857 | -19.1% | 1.08% | +9.9% |
| Q4 2021 | $8,954,000 | +959.6% | 6,350,694 | +749.7% | 0.98% | +1130.0% |
| Q3 2021 | $845,000 | -42.8% | 747,445 | -19.0% | 0.08% | -63.6% |
| Q2 2021 | $1,476,000 | +140.8% | 922,517 | +165.0% | 0.22% | +175.0% |
| Q1 2021 | $613,000 | – | 348,078 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |